cytarabine has been researched along with nutlin-3a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeff, M; Hashimoto, N; Honda, H; Ishizawa, J; Kai, K; Kanno, M; Kojima, K; Miwa, M; Nagata, K; Okada, S; Onishi, N; Saya, H; Shimizu, T; Sugihara, E | 1 |
| Laín, S; Rao, B; Sachweh, MC; van Leeuwen, IM | 1 |
| Ma, DD; Molloy, TJ; Röllig, C; Stölzel, F; Tursky, ML; Vu, TT; Wang, KW | 1 |
3 other study(ies) available for cytarabine and nutlin-3a
| Article | Year |
|---|---|
Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Bone Marrow Cells; Bone Marrow Transplantation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p16; Cytarabine; Disease Models, Animal; Flow Cytometry; Genes, myc; Hematopoietic Stem Cells; Humans; Imidazoles; Mice; Mice, Knockout; Piperazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cells, B-Lymphoid; Tumor Suppressor Protein p14ARF | 2012 |
An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Count; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Cytarabine; Dactinomycin; Drug Screening Assays, Antitumor; Fatty Acids, Unsaturated; Fibroblasts; HCT116 Cells; Humans; Imidazoles; Piperazines; Tumor Suppressor Protein p53; Vinblastine; Vinca Alkaloids; Vinorelbine | 2012 |
miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Biomarkers, Tumor; Cell Line, Tumor; Cytarabine; Female; Humans; Imidazoles; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; MicroRNAs; Piperazines; Proto-Oncogene Proteins c-mdm2 | 2021 |